Stem Cell Ophthalmology Treatment Study II
Public ClinicalTrials.gov record NCT03011541. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Bone Marrow Derived Stem Cell Ophthalmology Treatment Study II
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.
Study identification
- NCT ID
- NCT03011541
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 500 participants
Conditions and interventions
Conditions
- Retinal Disease
- Age-Related Macular Degeneration
- Retinitis Pigmentosa
- Stargardt Disease
- Optic Neuropathy
- Nonarteritic Ischemic Optic Neuropathy
- Optic Atrophy
- Optic Nerve Disease
- Glaucoma
- Leber Hereditary Optic Neuropathy
- Blindness
- Vision Loss Night
- Vision Loss Partial
- Vision, Low
- Retinopathy
- Maculopathy
- Macular Degeneration
- Retina Atrophy
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2015
- Primary completion
- Jul 30, 2027
- Completion
- Jul 30, 2028
- Last update posted
- Jun 28, 2026
2016 – 2028
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| MD Stem Cells | Westport | Connecticut | 06880 | Recruiting |
| MD Stem Cells | Coral Springs | Florida | 33065 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03011541, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 28, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03011541 live on ClinicalTrials.gov.